Following Watson's merger with Activis, my pharmacy began dispensing a Watson 3203 white oval pill for prescriptions written for 7.5 hydrocodone/3.25 APAP. Approximately 18 hours after my first dose, I began having withdrawals (chills, jerking limbs and torso,, rapid heartbeat, etc.). Additionally, there has never been any decline in the amount of pain from that first dose on. After doing some research and discovering other people having complaints and subsequent theories about the pill, my best guess is that Watson is using cheaper binders and fillers now that have drastically altered the bioavailability for some of us (in addition to maybe taking full advantage of the FDA's 20% loophole). Does anyone know if the CWE process will resolve this issue? I've read that at least some of the binders/fillers make it through the filter, but was wondering if they would still have the same detrimental effect?